Market closedNon-fractional
scPharmaceuticals/SCPH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About scPharmaceuticals
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
Ticker
SCPH
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Burlington, United States
Employees
136
Website
www.scpharmaceuticals.com
SCPH Metrics
BasicAdvanced
$180M
Market cap
-
P/E ratio
-$1.49
EPS
0.09
Beta
-
Dividend rate
Price and volume
Market cap
$180M
Beta
0.09
Financial strength
Current ratio
6.212
Quick ratio
5.257
Long term debt to equity
165.342
Total debt to equity
166.091
Interest coverage (TTM)
-7.22%
Management effectiveness
Return on assets (TTM)
-36.26%
Return on equity (TTM)
-114.99%
Valuation
Price to revenue (TTM)
10.959
Price to book
7.32
Price to tangible book (TTM)
7.32
Price to free cash flow (TTM)
-3.194
Growth
Revenue change (TTM)
754.68%
Earnings per share change (TTM)
14.23%
3-year earnings per share growth (CAGR)
6.74%
What the Analysts think about SCPH
Analyst Ratings
Majority rating from 6 analysts.
SCPH Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$6.1M
1.67%
Net income
-$14M
2.17%
Profit margin
-231.14%
0.50%
SCPH Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.36
-$0.41
-$0.35
-$0.36
-
Expected
-$0.37
-$0.36
-$0.42
-$0.44
-$0.40
Surprise
-3.33%
12.38%
-16.43%
-17.62%
-
SCPH News
AllArticlesVideos
scPharmaceuticals to Present at the Jefferies Global Healthcare Conference
GlobeNewsWire·2 months ago
scPharmaceuticals Inc. (SCPH) Q1 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for scPharmaceuticals stock?
scPharmaceuticals (SCPH) has a market cap of $180M as of July 27, 2024.
What is the P/E ratio for scPharmaceuticals stock?
The price to earnings (P/E) ratio for scPharmaceuticals (SCPH) stock is 0 as of July 27, 2024.
Does scPharmaceuticals stock pay dividends?
No, scPharmaceuticals (SCPH) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next scPharmaceuticals dividend payment date?
scPharmaceuticals (SCPH) stock does not pay dividends to its shareholders.
What is the beta indicator for scPharmaceuticals?
scPharmaceuticals (SCPH) has a beta rating of 0.09. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell scPharmaceuticals stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.